Nephrotic Syndrome vs Nephritic Syndrome
Both are clinical syndromes caused by glomerular disease, but they reflect different types of glomerular injury and have distinct presentations, causes, and management implications.
1. Nephrotic Syndrome
Pathophysiology: Caused by a derangement in the glomerular capillary wall (the endothelium-GBM-podocyte barrier) that increases its permeability to plasma proteins, without significant inflammation or cellular proliferation - Robbins, Cotran & Kumar Pathologic Basis of Disease. Heavy protein loss overwhelms hepatic synthetic capacity and is compounded by increased renal catabolism of filtered albumin.
Core clinical features (the "big 4"):
- Massive proteinuria - more than 3.5 g/day in adults (less in children)
- Hypoalbuminemia - serum albumin < 3 g/dL
- Generalized edema - the hallmark presenting complaint, from low plasma oncotic pressure ("underfill") plus primary renal Na+/water retention ("overfill") - Brenner and Rector's The Kidney, p. 2277
- Hyperlipidemia and lipiduria - from increased hepatic lipoprotein synthesis triggered by hypoalbuminemia and reduced lipid catabolism
Onset is typically insidious. Blood pressure and JVP are usually normal (or only mildly elevated). Hematuria may or may not occur, but RBC casts are absent.
Common causes:
- Minimal change disease (MCD) - most common in children; podocyte foot process fusion on EM, normal light microscopy
- Focal segmental glomerulosclerosis (FSGS)
- Membranous nephropathy - most common primary cause in adults
- Secondary causes: diabetic nephropathy, amyloidosis, lupus nephritis, drugs (NSAIDs can cause MCD-pattern nephrotic syndrome), infections
Complications: increased susceptibility to infection (loss of immunoglobulins), hypercoagulability/venous thromboembolism (loss of antithrombin III, increased hepatic procoagulant synthesis), vitamin D deficiency (loss of vitamin D-binding protein), and progressive CKD - risk correlates with the severity of proteinuria (marked risk when excretion exceeds 5 g/day) - Comprehensive Clinical Nephrology, p. 243.
2. Nephritic Syndrome
Pathophysiology: Driven by inflammation within the glomeruli - immune complex deposition or antibody-mediated injury triggers proliferation of glomerular cells and infiltration of leukocytes. This damages capillary walls (allowing RBCs to leak into urine) and produces hemodynamic changes that reduce GFR - Robbins, Cotran & Kumar Pathologic Basis of Disease.
Core clinical features:
- Hematuria - with dysmorphic RBCs and red cell casts (the most specific finding)
- Subnephrotic proteinuria (usually < 3.5 g/day), with or without edema
- Azotemia/oliguria - reduced GFR from glomerular injury
- Hypertension - from both fluid retention and renin release by ischemic kidneys
Onset is typically abrupt. Edema is present but less pronounced than in nephrotic syndrome; serum albumin is usually normal or only mildly reduced.
Common causes:
- Acute post-streptococcal (postinfectious) glomerulonephritis - classic in children, immune complexes with subepithelial deposits, abundant neutrophils
- IgA nephropathy
- Rapidly progressive (crescentic) glomerulonephritis (RPGN) - anti-GBM disease, immune-complex mediated, or ANCA-associated (pauci-immune) vasculitis; presents with nephritic features plus rapid loss of renal function
- Lupus nephritis (proliferative forms)
The classic pediatric presentation (post-streptococcal GN) involves rapid-onset oliguria, weight gain, generalized edema, and brown ("smoky" or tea-colored) urine over days, with circulating volume expansion, hypertension, and sometimes pulmonary edema without primary cardiac disease.
3. Side-by-Side Comparison
| Feature | Nephrotic Syndrome | Nephritic Syndrome |
|---|
| Onset | Insidious | Abrupt |
| Primary mechanism | Increased capillary wall permeability (non-inflammatory) | Glomerular inflammation/proliferation |
| Proteinuria | Massive (++++, >3.5 g/day) | Mild-moderate (++, subnephrotic) |
| Hematuria | May or may not occur | Prominent (+++), with RBC casts |
| RBC casts | Absent | Present |
| Edema | Marked (++++) | Present but milder (++) |
| Blood pressure | Usually normal | Usually raised |
| Serum albumin | Low | Normal or only slightly reduced |
| Hyperlipidemia/lipiduria | Present | Absent |
Adapted from Comprehensive Clinical Nephrology, p. 243.
4. Important Caveat
These are clinical patterns, not rigid diagnoses. Some glomerular diseases can present with either or both syndromes simultaneously - for example, membranoproliferative glomerulonephritis can manifest as nephrotic, nephritic, or a mixed picture, and proliferative lupus nephritis can cause nephrotic-range proteinuria despite an inflammatory (nephritic) lesion. Renal biopsy with light microscopy, immunofluorescence, and electron microscopy remains the definitive way to establish the underlying histologic diagnosis once the clinical syndrome narrows the differential.
Recent Evidence Note
Current management of nephrotic syndrome (steroids, calcineurin inhibitors, rituximab for relapsing/steroid-dependent disease) is supported by recent systematic reviews: a 2025 Cochrane review on interventions for idiopathic steroid-resistant nephrotic syndrome in children (PMID: 40337980), and a 2024 systematic review/meta-analysis on immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome (PMID: 39083488). These support individualized immunosuppressive strategies beyond corticosteroids alone but don't fundamentally change the classic pathophysiology/clinical framework above.